Compare DRIO & NA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DRIO | NA |
|---|---|---|
| Founded | 2011 | 2019 |
| Country | United States | China |
| Employees | 165 | N/A |
| Industry | Medical/Dental Instruments | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.8M | 51.9M |
| IPO Year | 2013 | 2021 |
| Metric | DRIO | NA |
|---|---|---|
| Price | $5.52 | $2.19 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $13.60 | N/A |
| AVG Volume (30 Days) | 14.7K | ★ 32.6K |
| Earning Date | 11-12-2026 | 08-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1559.02 | N/A |
| EPS | ★ 1.75 | N/A |
| Revenue | ★ $7,394,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $38.77 | N/A |
| P/E Ratio | $3.10 | ★ N/A |
| Revenue Growth | ★ 43.02 | N/A |
| 52 Week Low | $5.43 | $1.58 |
| 52 Week High | $16.50 | $5.97 |
| Indicator | DRIO | NA |
|---|---|---|
| Relative Strength Index (RSI) | 39.32 | 46.10 |
| Support Level | N/A | $1.64 |
| Resistance Level | $8.01 | $2.44 |
| Average True Range (ATR) | 0.39 | 0.12 |
| MACD | -0.09 | -0.03 |
| Stochastic Oscillator | 24.57 | 8.33 |
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.
Nano Labs Ltd is a Web 3.0 infrastructure and product solution provider, as well as a crypto treasury company. It is focused on the development of HTC chips and HPC chips. In addition, the company has established BNB value investment and adopted BNB (a crypto token) as the primary reserve asset. Furthermore, it has launched the iPollo Claw, a dedicated hardware solution for the OpenClaw AI Agent Ecosystem. Nano Labs derives revenue mainly from its HTC and HPC offerings, which comprise Darkbird series HPC chips that feature high performance and high energy consumption efficiency, and Cuckoo series chips, used in GPUs. Geographically, the company generates maximum revenue from the People's Republic of China (PRC), and the rest from Singapore, Hong Kong, the United States, and other markets.